<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01104740</url>
  </required_header>
  <id_info>
    <org_study_id>10/B/01</org_study_id>
    <secondary_id>2010-A00385-34</secondary_id>
    <nct_id>NCT01104740</nct_id>
  </id_info>
  <brief_title>Dengue Seroprevalence Study in Blood Donors in the French West Indies</brief_title>
  <acronym>DengSeroprevAn</acronym>
  <official_title>Dengue Seroprevalence Study in Blood Donors in the French West Indies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Etablissement Français du Sang, Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Sanofi Pasteur, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Clinique Antilles-Guyane</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Etablissement Français du Sang, Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dengue is an infectious disease most prevalent in the world. This disease is endemic in the&#xD;
      Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent&#xD;
      years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have&#xD;
      emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a&#xD;
      classical form with fever, and even of severe or lethal bleeding. With the possible existence&#xD;
      of silent forms of the disease, there are no data identifying the current level of protection&#xD;
      of the population in Martinique / Guadeloupe.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Principal objective:&#xD;
&#xD;
           To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood&#xD;
           donors in the French West Indies.&#xD;
&#xD;
        2. Secondary objective:&#xD;
&#xD;
      To specify the serotypic specificity of the anti-dengue antibodies detected during the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or not of dengue virus-specific immunoglobulin G antibodies</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characterization of dengue virus serotype-specific IgG</measure>
    <time_frame>1 day</time_frame>
    <description>Characterization of dengue virus serotype-psecific IgG whendengue virus serotype-specific immunoglobulin G antibodies Test is positive</description>
  </secondary_outcome>
  <enrollment type="Actual">817</enrollment>
  <condition>Blood Donors</condition>
  <condition>Dengue</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biological sample collection</intervention_name>
    <description>Blood (serum) sample collection</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult, résidents in Martinique/ Guadeloupe (french west indies), aged 18 to 65 years coming&#xD;
        to give their blood in one of the building or mobile collection facilities of the French&#xD;
        Blood Establishment in French West Indies.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Eligible for blood donation following the French legislation,&#xD;
&#xD;
          -  Resident in Martinique /Guadeloupe for at least one year&#xD;
&#xD;
          -  Consent signed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not Eligible for blood donation following the French legislation,&#xD;
&#xD;
          -  Not Resident in Martinique / Guadeloupe for at least one year&#xD;
&#xD;
          -  Consent not signed&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascale RICHARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>French Blood Establishment of Martinique</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>French Blood Establishment of Guadeloupe</name>
      <address>
        <city>Pointe-à-Pitre</city>
        <zip>97171</zip>
        <country>Guadeloupe</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>French Blood Establishment of Martinique</name>
      <address>
        <city>Fort-de-France</city>
        <zip>97264</zip>
        <country>Martinique</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Guadeloupe</country>
    <country>Martinique</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 14, 2010</study_first_submitted>
  <study_first_submitted_qc>April 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 15, 2010</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Etablissement Français du Sang, Martinique</investigator_affiliation>
    <investigator_full_name>RICHARD</investigator_full_name>
    <investigator_title>Directrice EFS Martinique</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dengue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

